Bram Herman, Ph.D.

Critic
DISC Type : C

Director of Emerging Technologies ( Genomics R&D) at Agilent Technologies

Letchworth, England, United Kingdom

Overview

Bram Herman is the Director of Emerging Technologies in the Genomics R&D division at Agilent Technologies. With a Ph. D. from the University of Warwick, he leads a team focused on technical M&A diligence and driving innovation by evaluating emerging technologies and applications in genomics.

He is deeply engaged in the scientific community, evidenced by his publications on sensitive mutation detection and his active promotion of innovative solutions and partnerships in his field. He also shows an interest in continuous learning, sharing courses he has found valuable.

Unique fact: Bram holds a patent for a method that uses CAS9 technology for fragmenting genomic DNA.

Personality Overview

ROI Driven

Precise

Information Seeker

They prefer to do logical analysis and value evidence over emotions.  Unless the value is proven by data, they are unlikely to value fancy features. They enjoy working alone and do not rely on others very often.

Topics They Care About

Emerging Genomics Tech
As Director of Emerging Technologies, his primary role is to evaluate and integrate new technologies, applications, and potential M&A opportunities for Agilent's genomics division.
R&D Partnerships
He has a background as a Strategic Collaborations Manager and recently highlighted successful partnerships with companies like Tagomics and Avida Biomed to advance genomics solutions.
Liquid Biopsy
His past work and publications focus heavily on developing solutions for liquid biopsy, including ultra-sensitive mutation detection from circulating tumor DNA (cfDNA).

Media Appearances

Bram has no verified media appearances

Work History

6-2021
Director of Emerging Technologies ( Genomics R&D) at Agilent Technologies
6-2016 - 6-2021
Strategic Collaborations Manager - Genomics at Agilent Technologies
1-2016 - 2025
Life science liaison board member at University of Bedfordshire
11-2013 - 6-2016
Senior Genomics FAS and NGS Application Development Coordinator (EMEAI) at Agilent Technologies
4-2010 - 11-2013
Sr. Genomics Field Application Specialist at Agilent Technologies

Education

2005 - 2009
PhD from University of Warwick
2004 - 2005
MSc by research from Coventry University

More Information

Social Presence :

Prographics :

Exp : 20 Location : Letchworth, England, United Kingdom Job Level : Mid-senior Designation : Director of Emerging Technologies ( Genomics R&D) at Agilent Technologies
URL has been copied!

Insights For Selling To Bram

During A Call Or A Meeting

DO's

  • Be ready to answer many clarity-seeking questions and requests for information
  • Tell them what ROI they can expect
  • Use phrases like ‘expect X% improvement’, ‘data clearly shows’ etc.

DONT's

  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Make extra effort to not seem pushy or confrontational
  • Don't give superficial answers, they are easily rattled by them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Bram is

  • Strong evidence of ROI, effective pricing, and proven data points matter the most to them.
  • Will you ever get a clear answer from Bram

  • It is not very hard for them to say no if they are not convinced about the decision.

Insights For Deal Planning

    How fast (or slow) will Bram move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Bram take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Bram

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.